The Clinical Effects of C2 and C3 Medial Branch Block for Medically Intractable Headache : a Retrospective Study.

IF 1.4 4区医学 Q4 CLINICAL NEUROLOGY

Journal of Korean Neurosurgical Society Pub Date : 2024-06-20 DOI:10.3340/jkns.2024.0004

Moonyoung Chung, Won Hee Lee

{"title":"The Clinical Effects of C2 and C3 Medial Branch Block for Medically Intractable Headache : a Retrospective Study.","authors":"Moonyoung Chung, Won Hee Lee","doi":"10.3340/jkns.2024.0004","DOIUrl":null,"url":null,"abstract":"Objective: This study aimed to evaluate the clinical effects of medial branch blocks (MBB) C2 and C3 in treating patients with medically intractable headaches.Methods: The medical records of 81 patients with medically intractable headaches who underwent a C2/3 MBB between January 2019 and March 2022 were retrospectively reviewed. The degrees of pain were evaluated using a visual analogue scale (VAS) score (rating 0-10) on baseline and after procedures. To evaluate patients' satisfaction for the treatment, self-reporting measurements were examined and were categorized as excellent (>90% pain relief), good (50%-90% pain relief), fair (10%-50% pain relief), and none (<10% pain relief).Results: The total number of MBB procedure was 107. The average baseline VAS score was 7.4 ±1.5, which improved significantly to 2.6 ±2.3, 3.6 ±2.6, and 4.5 ±3.2 on 1-3 days, 3-7 days, and 3 months after the procedure, respectively (Wilks' lambda within group test, P <0.001). For the subjective feeling of pain relief, percentages of \"excellent\" response in the self-reporting measurements were significantly decreased over time (chi-square test; P= 0.001).Conclusion: This study demonstrates clinical effectiveness of C2/3 MBB in patients with medically intractable headaches, with both early and prolonged benefits.","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Neurosurgical Society","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3340/jkns.2024.0004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: This study aimed to evaluate the clinical effects of medial branch blocks (MBB) C2 and C3 in treating patients with medically intractable headaches.

Methods: The medical records of 81 patients with medically intractable headaches who underwent a C2/3 MBB between January 2019 and March 2022 were retrospectively reviewed. The degrees of pain were evaluated using a visual analogue scale (VAS) score (rating 0-10) on baseline and after procedures. To evaluate patients' satisfaction for the treatment, self-reporting measurements were examined and were categorized as excellent (>90% pain relief), good (50%-90% pain relief), fair (10%-50% pain relief), and none (<10% pain relief).

Results: The total number of MBB procedure was 107. The average baseline VAS score was 7.4 ±1.5, which improved significantly to 2.6 ±2.3, 3.6 ±2.6, and 4.5 ±3.2 on 1-3 days, 3-7 days, and 3 months after the procedure, respectively (Wilks' lambda within group test, P <0.001). For the subjective feeling of pain relief, percentages of "excellent" response in the self-reporting measurements were significantly decreased over time (chi-square test; P= 0.001).

Conclusion: This study demonstrates clinical effectiveness of C2/3 MBB in patients with medically intractable headaches, with both early and prolonged benefits.

查看原文本刊更多论文

C2 和 C3 内侧支阻滞治疗医学上难治性头痛的临床效果：一项回顾性研究。

研究目的本研究旨在评估C2和C3内侧支阻滞（MBB）治疗医学难治性头痛患者的临床效果：方法：回顾性审查了在 2019 年 1 月至 2022 年 3 月期间接受 C2/3 MBB 的 81 例医学难治性头痛患者的病历。使用视觉模拟量表（VAS）评分（0-10 分）评估基线和手术后的疼痛程度。为了评估患者对治疗的满意度，对患者的自我报告进行了检查，并将其分为优（疼痛缓解>90%）、良（疼痛缓解50%-90%）、一般（疼痛缓解10%-50%）和无（结果：MBB 手术总数为 107 例。基线 VAS 评分平均值为 7.4 ±1.5，术后 1-3 天、3-7 天和 3 个月分别显著改善为 2.6 ±2.3、3.6 ±2.6、4.5 ±3.2（Wilks' lambda 组内检验，P 结论：本研究表明，C2/3 MBB 对药物难治性头痛患者的临床疗效显著，既能早期获益，也能长期获益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Korean Neurosurgical Society 医学-临床神经学

CiteScore

2.90

自引率

6.20%

发文量

109

审稿时长

3-8 weeks

期刊介绍： The Journal of Korean Neurosurgical Society (J Korean Neurosurg Soc) is the official journal of the Korean Neurosurgical Society, and published bimonthly (1st day of January, March, May, July, September, and November). It launched in October 31, 1972 with Volume 1 and Number 1. J Korean Neurosurg Soc aims to allow neurosurgeons from around the world to enrich their knowledge of patient management, education, and clinical or experimental research, and hence their professionalism. This journal publishes Laboratory Investigations, Clinical Articles, Review Articles, Case Reports, Technical Notes, and Letters to the Editor. Our field of interest involves clinical neurosurgery (cerebrovascular disease, neuro-oncology, skull base neurosurgery, spine, pediatric neurosurgery, functional neurosurgery, epilepsy, neuro-trauma, and peripheral nerve disease) and laboratory work in neuroscience.